| abstract |
(57) SUMMARY Somatostatin agonist compounds of formula (I) are disclosed, including pharmaceutically acceptable salts and hydrates. The compounds are useful in treating diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome and pain. The compounds are potent and have high selectivity for receptor subtype (2). Also included are pharmaceutical compositions and methods of treatment. |